Αποτελέσματα Αναζήτησης
5 Ιαν 2012 · Two previous studies of a herpes simplex virus type 2 (HSV-2) subunit vaccine containing glycoprotein D in HSV-discordant couples revealed 73% and 74% efficacy against genital disease in...
- Maternal and Neonatal Herpes Simplex Virus Infections
Whether it is caused by herpes simplex virus (HSV) type 1 or...
- NEJM
Serologic surveys indicate that the prevalence of infection...
- Maternal and Neonatal Herpes Simplex Virus Infections
3 Ιουν 2016 · We will provide an overview of efforts to develop HSV-2 vaccines, including a discussion of the clinical need for an HSV vaccine, and status of research and development with an emphasis on recent insights from trials of vaccine candidates in clinical testing.
Moderna is developing a vaccine using mRNA technology to treat the herpes simplex virus (HSV). There are two HSV virus types — HSV-1, the one I have, that affects the mouth, face and...
Herpes simplex virus fact sheet with key facts and information on type 1 (HSV-1) and type 2 (HSV-2): signs and symptoms, transmission, challenges, treatment, global impact and WHO response.
14 Μαΐ 2019 · PPCs for prophylactic HSV vaccines to be used primarily before exposure to HSV-2 to prevent infection. Prevention of HSV-2 infection would prevent associated GUD and HSV transmission, including to neonates as neonatal herpes, as well as HSV-2-associated HIV acquisition.
11 Μαρ 2016 · Objectives. The objectives of these guidelines are: to provide evidence-based guidance on treatment of genital HSV infection; and. to support countries to update their national guidelines for treatment of genital HSV infection.
Led by principal investigator Lesia K. Dropulic, M.D., of NIAID’s Laboratory of Infectious Diseases, the trial will test an investigational HSV-2 vaccine candidate, called HSV529, for safety and the ability to generate an immune system response.
